Jim Simons’s Ascendis Pharma A/S ASND Stock Holding History

Jim Simons’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.9M	Buy	119,699 +2,367	+2%	+$553K	0.04%	505
2026 Q1	$26.8M	Buy	+117,332	New	+$26.3M	0.04%	543
2023 Q3	–	Sell	-82,699	Closed	-$7.38M	–	3642
2023 Q2	$7.38M	Buy	+82,699	New	+$7.2M	0.01%	1186
2020 Q3	–	Sell	-55,082	Closed	-$8.15M	–	3362
2020 Q2	$8.15M	Buy	55,082 +4,004	+8%	+$550K	0.01%	1348
2020 Q1	$5.75M	Buy	51,078 +21,235	+71%	+$2.76M	0.01%	1485
2019 Q4	$4.15M	Sell	29,843 -44,756	-60%	-$4.97M	﹤0.01%	1970
2019 Q3	$7.18M	Sell	74,599 -105,200	-59%	-$11.7M	0.01%	1603
2019 Q2	$20.7M	Buy	179,799 +91,000	+102%	+$10.9M	0.02%	944
2019 Q1	$10.5M	Buy	+88,799	New	+$7.78M	0.01%	1353
2018 Q4	–	Sell	-41,900	Closed	-$2.97M	–	3366
2018 Q3	$2.97M	Sell	41,900 -14,600	-26%	-$1M	﹤0.01%	2086
2018 Q2	$3.76M	Buy	56,500 +49,860	+751%	+$3.28M	﹤0.01%	1955
2018 Q1	$434K	Sell	6,640 -8,860	-57%	-$498K	﹤0.01%	2961
2017 Q4	$621K	Sell	15,500 -18,000	-54%	-$654K	﹤0.01%	2833
2017 Q3	$1.21M	Buy	33,500 +8,030	+32%	+$230K	﹤0.01%	2504
2017 Q2	$707K	Buy	+25,470	New	+$673K	﹤0.01%	2675

Other funds holding ASND

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Jim Simons's ASND Position: Q2 2026 in Review

Jim Simons increased its Ascendis Pharma A/S (ASND) stake by 2% in Q2 2026, buying an estimated $553K and bringing the position to 119,699 shares worth $31.9M. The position accounts for 0.04% of the portfolio, ranked #505.

Jim Simons first reported a position in ASND in Q2 2017 and has held it in 15 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Jim Simons held 119,699 shares of Ascendis Pharma A/S worth $31.9M as of Q2 2026.
Jim Simons bought 2,367 Ascendis Pharma A/S shares in Q2 2026, an estimated $553K.
Ascendis Pharma A/S made up 0.04% of Jim Simons's portfolio in Q2 2026, its #505 holding.
Jim Simons first reported a position in Ascendis Pharma A/S in Q2 2017 and has held it in 15 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.